Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tindall

Showing results (111-120 of 571) with videos related to

Pageof 58
Sort By:
The Journal of Urology|February 19, 2008
The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancerDonald J Tindall, Roger S Rittmaster
Current Drug Targets|March 20, 2003
TGF-betal/Smad signaling in prostate cancerDiana Bello-DeOcampo, Donald J Tindall
International Journal of Systematic and Evolutionary Microbiology|January 2, 2003
Necessary corrections to the Approved Lists of Bacterial Names according to Rule 40d (formerly Rule 46). Request for an opinionJ P Euzéby, B J Tindall
Endocrine-Related Cancer|July 23, 2011
Alternatively spliced androgen receptor variantsScott M Dehm, Donald J Tindall
Journal of Carcinogenesis|September 3, 2011
Androgen receptor signaling in prostate cancer development and progressionPeter E Lonergan, Donald J Tindall
Nature Reviews. Urology|June 2, 2011
Targeting 5α-reductase for prostate cancer prevention and treatmentLucas P Nacusi, Donald J Tindall
Cancer Research|April 1, 1996
Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaPJ E Perry, D J Tindall
The American Journal of the Medical Sciences|March 1, 1978
A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTHJ C Nelson, D J Tindall
Cancer Letters|October 3, 2002
The role of androgens and the androgen receptor in prostate cancerJose D Debes, Donald J Tindall
The Journal of Biological Chemistry|May 5, 1995
The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNAM E Grossmann, D J Tindall
Pageof 58

Showing results (111-120 of 571) with videos related to

Sort By:
Pageof 58
The Journal of Urology|February 19, 2008
The rationale for inhibiting 5alpha-reductase isoenzymes in the prevention and treatment of prostate cancerDonald J Tindall, Roger S Rittmaster
Current Drug Targets|March 20, 2003
TGF-betal/Smad signaling in prostate cancerDiana Bello-DeOcampo, Donald J Tindall
International Journal of Systematic and Evolutionary Microbiology|January 2, 2003
Necessary corrections to the Approved Lists of Bacterial Names according to Rule 40d (formerly Rule 46). Request for an opinionJ P Euzéby, B J Tindall
Endocrine-Related Cancer|July 23, 2011
Alternatively spliced androgen receptor variantsScott M Dehm, Donald J Tindall
Journal of Carcinogenesis|September 3, 2011
Androgen receptor signaling in prostate cancer development and progressionPeter E Lonergan, Donald J Tindall
Nature Reviews. Urology|June 2, 2011
Targeting 5α-reductase for prostate cancer prevention and treatmentLucas P Nacusi, Donald J Tindall
Cancer Research|April 1, 1996
Androgens regulate the expression of proliferating cell nuclear antigen posttranscriptionally in the human prostate cancer cell line, LNCaPJ E Perry, D J Tindall
The American Journal of the Medical Sciences|March 1, 1978
A comparison of the adrenal responses to hypoglycemia, metyrapone and ACTHJ C Nelson, D J Tindall
Cancer Letters|October 3, 2002
The role of androgens and the androgen receptor in prostate cancerJose D Debes, Donald J Tindall
The Journal of Biological Chemistry|May 5, 1995
The androgen receptor is transcriptionally suppressed by proteins that bind single-stranded DNAM E Grossmann, D J Tindall
Pageof 58